Aspire Biopharma Warrant
ASBPW
29 hedge funds and large institutions have $408K invested in Aspire Biopharma Warrant in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
7% more funds holding
Funds holding: 27 → 29 (+2)
39% less capital invested
Capital invested by funds: $667K → $408K (-$259K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$25.5K |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
+$7.41K |
| 3 |
VAS
VR Advisory Services
Camana Bay, Grand Cayman,
Cayman Islands
|
+$4.92K |
| 4 |
FTUS
Flow Traders U.S.
New York
|
+$15 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sculptor Capital
New York
|
-$94.1K |
| 2 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
-$16.9K |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$14K |
| 4 |
RFA
Reyes Financial Architecture
San Diego,
California
|
-$4 |
| 5 |
FFA
Farther Finance Advisors
San Francisco,
California
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BOCH
26
Blue Owl Capital Holdings
New York
| $2.23K | – | – | – |
|
|
OAC
27
OMERS Administration Corp
Toronto,
Ontario, Canada
| $1.12K | – | – | – |
|
|
PMAM
28
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
FTUS
29
Flow Traders U.S.
New York
| $1K | +$15 | +300 | +2% |
|
|
30
Osaic Holdings
Scottsdale,
Arizona
| $2 | +$2 | +50 | New |
|
|
AIMCA
31
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
| – | -$16.9K | -250,000 | Closed |
|
|
RFA
32
Reyes Financial Architecture
San Diego,
California
| – | -$4 | -70 | Closed |
|
|
FFA
33
Farther Finance Advisors
San Francisco,
California
| – | -$1 | -10 | Closed |
|
ASBPW Hedge Fund Activity: Q2 2025 in Review
29 of the 7,599 institutional investors tracked by Wall St. Rank reported a position in Aspire Biopharma Warrant (ASBPW) for Q2 2025, worth a combined $408K — down 39% from $667K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ASBPW positions and 3 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Toronto Dominion Bank, opening a new position worth an estimated $25.5K. The largest seller was Sculptor Capital, cutting an estimated $94.1K.
- 29 institutional investors held Aspire Biopharma Warrant (ASBPW) as of Q2 2025, up from 27 in Q1 2025.
- Funds reported $408K of Aspire Biopharma Warrant stock for Q2 2025, down 39% quarter-over-quarter.
- 6 funds opened new Aspire Biopharma Warrant positions in Q2 2025 and 3 closed out, a net change of +3 holders.
- The largest Aspire Biopharma Warrant buyer in Q2 2025 was Toronto Dominion Bank, an estimated $25.5K added.
- The largest Aspire Biopharma Warrant seller in Q2 2025 was Sculptor Capital, an estimated $94.1K sold.
Based on aggregated 13F filings for Q2 2025.